Study Links Eating Five or More Eggs Per Week to Lower Alzheimer's Risk

A large observational study published in the Journal of Nutrition in May 2026 reported that adults who ate at least five eggs per week had a 27% lower risk of being diagnosed with Alzheimer's disease compared to those who never ate eggs [1]. The finding, drawn from roughly 40,000 participants in the Adventist Health Study-2 cohort tracked for an average of 15.3 years, landed in headlines worldwide and reignited a long-running debate about eggs, brain health, and the reliability of nutrition research funded in part by the food industry.

The question is straightforward: should people eat more eggs to protect their brains? The answer is not.

The Study: Design, Population, and Numbers

The research, led by Jisoo Oh, an associate professor of epidemiology at Loma Linda University, and principal investigator Joan Sabaté, analyzed data from the Adventist Health Study-2 — a long-running cohort of Seventh-day Adventists enrolled beginning in 2007 [1][2]. Only participants aged 65 and older at enrollment were included. Alzheimer's diagnoses were identified through physician records in Medicare billing data [3].

Dietary intake was measured once, at baseline, using a comprehensive questionnaire that captured both direct egg consumption (scrambled, fried, boiled) and indirect sources like baked goods and packaged foods [3].

The risk reductions followed a dose-response pattern:

• 1–3 times per month: 17% lower risk
• 2–4 times per week: 20% lower risk
• 5 or more times per week: 27% lower risk [1][2]

Source: Journal of Nutrition / Loma Linda University

Data as of May 6, 2026CSV

Researchers adjusted for age, sex, race, education, physical activity, sleep, hypertension, diabetes, heart disease, and overall dietary patterns including consumption of nuts, seeds, and legumes [3].

This is an observational cohort study — not a randomized controlled trial. "This is an observational study, so we cannot establish causation," Oh stated explicitly [3]. Participants were not assigned to eat eggs or avoid them; they reported their existing habits. The design can identify associations but cannot prove that eggs caused the risk reduction.

The Biological Case: Choline and Beyond

The study's authors and other researchers have pointed to several nutrients concentrated in eggs as plausible mechanisms for neuroprotection.

Choline is the leading candidate. A single large egg contains roughly 147 milligrams of choline — about 27% of the daily adequate intake. Choline is a precursor to acetylcholine, a neurotransmitter central to memory and learning. It also supports cell membrane integrity through phosphatidylcholine production and influences gene expression through epigenetic mechanisms [4][5].

A separate 2024 study using the Rush Memory and Aging Project found that about 39% of the association between egg consumption and reduced Alzheimer's risk was statistically mediated through dietary choline intake [5]. That study, which included brain autopsies of deceased participants, also found that regular egg consumers had lower levels of amyloid plaques and tau tangles — the hallmark proteins of Alzheimer's pathology [5].

Beyond choline, eggs contain lutein and zeaxanthin — carotenoids that accumulate in brain tissue and have been linked to reduced oxidative stress and improved cognitive performance [2]. Phospholipids, which make up roughly 30% of egg lipids, affect neurotransmitter receptor function [2]. Eggs also provide omega-3 fatty acids, vitamin B12 (whose deficiency raises homocysteine, a recognized Alzheimer's risk factor), and vitamin D [4].

How Does 27% Compare to Other Interventions?

A 27% risk reduction sounds significant, but context matters. The NIH-funded study of combined healthy lifestyle factors found that people who adhered to four or five healthy behaviors — physical activity, not smoking, light-to-moderate alcohol consumption, a high-quality diet, and cognitive engagement — had a 60% lower risk of Alzheimer's compared to those with zero or one healthy behavior [6]. Even adhering to just two or three of those behaviors yielded a 37% reduction [6].

The Finnish Geriatric Intervention Study (FINGER), a randomized controlled trial of 1,260 individuals, demonstrated that a two-year multimodal intervention combining diet, exercise, cognitive training, and vascular risk monitoring produced measurable improvements in cognitive function among high-risk individuals [7].

Mediterranean and MIND diet adherence, both supported by stronger evidence bases than single-food studies, have been associated with reduced dementia risk across multiple populations [7]. Exercise alone has shown consistent associations with lower Alzheimer's risk in meta-analyses [7].

In this landscape, a 27% reduction from a single dietary component — measured observationally, in one cohort — sits below the effect sizes seen for comprehensive lifestyle interventions and roughly comparable to individual components like regular physical activity.

The Funding Question

Partial funding for the Loma Linda study came from the American Egg Board through an investigator-initiated grant. The researchers stated that the funder "had no role in design, execution, data analysis, or manuscript preparation" [3]. The National Institutes of Health funded the establishment of the original Adventist Health Study-2 cohort through a National Cancer Institute grant (1U01CA152939) [3].

This disclosure matters because of a documented pattern in egg-related nutrition research. A 2021 systematic review published in the American Journal of Lifestyle Medicine found that the proportion of industry-funded studies on dietary cholesterol rose from 0% in the 1950s to 60% by 2010–2019 [8]. Among industry-funded studies, 49% showed disagreement between their data and their conclusions — interpreting cholesterol increases as favorable or insignificant — compared to 13% of independently funded studies [8].

The American Egg Board's research arm, the Egg Nutrition Center, funds studies explicitly to "increase demand for egg and egg products on behalf of U.S. egg producers" [9]. Critics including Marion Nestle, professor emerita of nutrition at New York University, have documented cases where Egg Nutrition Center-funded meta-analyses relied heavily on other industry-funded research, sometimes while investigators simultaneously served on the Dietary Guidelines Advisory Committee [9][10].

None of this proves the Loma Linda findings are wrong. But it places them in a context where independent replication is essential before translating the results into dietary recommendations.

The Confounder Problem

The study population introduces a significant complication. Seventh-day Adventists, as a group, smoke less, drink less alcohol, eat more plant-based foods, and have lower baseline rates of obesity, diabetes, and cardiovascular disease than the general American population [3][11]. The results reflect what happens when people add eggs to an already protective dietary pattern — not to the typical Western diet.

Researchers controlled for many variables, but as Oh acknowledged, "residual confounding cannot be entirely ruled out in observational studies of this nature" [3]. People who eat eggs five or more times per week may differ from non-egg consumers in ways the questionnaire did not capture — cooking habits, meal regularity, overall protein intake, food access, or socioeconomic factors that correlate with both diet quality and dementia risk.

Dietary intake was measured only once, at enrollment. Over a 15-year follow-up, eating patterns change substantially. A participant classified as a frequent egg consumer in 2007 may have shifted their diet by 2015 or 2020 [3].

The Cholesterol Debate, Unresolved

For decades, eggs were discouraged because of their high dietary cholesterol content — about 186 milligrams per large egg. The 2015–2020 Dietary Guidelines for Americans removed the previous 300 mg/day cholesterol limit, and eggs were partially rehabilitated [12].

But the controversy has not been formally resolved. A 2019 meta-analysis found that consuming one egg daily raises LDL ("bad") cholesterol by about 9 mg/dL [8]. While 93% of non-industry-funded studies reported net cholesterol increases from egg consumption, industry-funded studies were far more likely to frame these increases as clinically insignificant [8].

For Alzheimer's researchers, this creates a tension: the same food being studied for brain protection may carry cardiovascular risks that themselves contribute to dementia through vascular pathways. Cardiovascular disease is an established risk factor for cognitive decline [12].

Who Benefits — and Who Doesn't

Eggs are among the cheapest complete protein sources available globally, typically costing $0.20–0.30 per egg in the United States. For low-income populations with limited access to fatty fish, nuts, or supplements, eggs represent a realistic source of choline, B vitamins, and other brain-supporting nutrients [2].

However, several populations cannot act on this finding. Approximately 2% of children have egg allergies (the most common food allergy in many countries), with some carrying the allergy into adulthood [11]. Vegans — roughly 3% of the U.S. population — exclude eggs by definition. Some cultural and religious dietary traditions limit or exclude egg consumption.

The Alzheimer's Association estimates that 6.9 million Americans aged 65 and older were living with Alzheimer's dementia in 2024, with the number projected to reach 13.8 million by 2060 in the absence of effective prevention or treatment [13]. Globally, dementia cases are projected to rise from 57.4 million in 2019 to roughly 153 million by 2050 [14].

Source: Lancet Global Health / WHO

Data as of Sep 1, 2024CSV

If the 27% risk reduction were causal and applied at the population level — both enormous assumptions — it would theoretically translate to preventing or delaying hundreds of thousands of new cases per year in the United States alone. But extrapolating from a single observational study of Seventh-day Adventists to global population-level effects requires evidence that does not yet exist.

The Cost Dimension

The financial stakes of Alzheimer's prevention are staggering. In 2025, medical and long-term care for U.S. dementia patients cost an estimated $232 billion, with Medicare covering $106 billion and Medicaid $58 billion [13]. By 2026, total costs are projected to reach $409 billion [13]. Average per-person Medicare payments for beneficiaries with Alzheimer's are nearly three times those for beneficiaries without dementia [13].

Beyond direct medical costs, 11.3 million informal caregivers provided 16 billion hours of unpaid care in 2022, valued at $271.6 billion [14]. The total cost of caring for one individual with Alzheimer's from diagnosis to death averages $412,936, with 70% borne by families [14].

Globally, the economic burden is projected to reach $16.9 trillion by 2050 [14]. Low- and middle-income countries, where egg consumption patterns and healthcare access differ markedly from the study population, would account for 65% of that burden [14].

A population-level 27% reduction — again, hypothetically — would represent enormous savings. But the gap between an observational association in one cohort and a validated, implementable public health intervention remains wide.

What Skeptics Say

Several limitations weaken the case for translating this finding into dietary guidance.

First, the study used Medicare billing codes to identify Alzheimer's cases — an approach that may miss early-stage disease and capture diagnosis patterns shaped by healthcare access rather than true incidence [3].

Second, the dose-response curve is relatively flat: the difference between eating eggs 1–3 times per month (17% reduction) and 5+ times per week (27% reduction) is only 10 percentage points across a roughly 15-fold increase in consumption. This modest gradient could reflect confounding rather than a true dose-response effect.

Third, the history of observational nutrition studies overturning in randomized trials is long. Hormone replacement therapy, beta-carotene supplements, and vitamin E all showed promising associations in observational data that collapsed or reversed in controlled trials [11].

"Research supports eggs as part of a healthy diet," Oh said, deliberately framing the finding within a broader dietary context rather than as a standalone recommendation [2].

The Research Landscape

Academic interest in the intersection of diet, nutrition, and Alzheimer's prevention has grown substantially. Over 101,000 papers on Alzheimer's disease prevention have been indexed since 2011, peaking at more than 14,000 in 2023 [15]. Research specifically on choline, eggs, and Alzheimer's reached 116 publications in 2024 [15].

Source: OpenAlex

Data as of Jan 1, 2026CSV

Source: OpenAlex

Data as of Jan 1, 2026CSV

This body of work increasingly supports the idea that dietary patterns — not individual foods — drive meaningful differences in dementia risk. The MIND diet, which emphasizes green leafy vegetables, berries, nuts, whole grains, fish, and poultry while limiting red meat, butter, cheese, and sweets, has shown associations with slower cognitive decline in multiple cohorts [7].

What Comes Next

The Loma Linda study adds to a growing body of evidence suggesting that choline-rich diets may support brain health in aging. The earlier Rush Memory and Aging Project findings — including autopsy data showing lower amyloid and tau pathology in egg consumers — strengthen the biological plausibility [5].

But biological plausibility and observational association are not proof. Before eggs can be recommended as an Alzheimer's prevention strategy, researchers would need to demonstrate the effect in randomized controlled trials, in diverse populations, with longer and more detailed dietary tracking, and with independent funding.

For now, the most evidence-based approach to reducing Alzheimer's risk remains a combination of regular physical activity, cardiovascular risk management, cognitive engagement, adequate sleep, and a varied, nutrient-dense diet [6][7]. Eggs can be part of that diet. Whether they are a key driver of neuroprotection — or a marker for other healthy behaviors — remains an open question.